{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:03:40Z","timestamp":1789398220488,"version":"build-2803163510"},"reference-count":21,"publisher":"Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,9]]},"DOI":"10.31744\/einstein_journal\/2026rc1788","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:11:31Z","timestamp":1789395091000},"source":"Crossref","is-referenced-by-count":0,"title":["X-linked hypophosphatemic rickets: case report with perspectives and challenges"],"prefix":"10.31744","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9415-0971","authenticated-orcid":false,"given":"Beatriz Almeida","family":"Ribeiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7834-6829","authenticated-orcid":false,"given":"Henrique Massashi","family":"Soga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9266-9964","authenticated-orcid":false,"given":"Fernanda Teresa de","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4267-4567","authenticated-orcid":false,"suffix":"J\u00fanior","given":"Amancio","family":"Ramalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6758-9143","authenticated-orcid":false,"given":"Cintia Giunchetti Strabelli","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9164-9280","authenticated-orcid":false,"given":"Eduardo Juan","family":"Troster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1930-7921","authenticated-orcid":false,"given":"Teresa Cristina Gomes Alfinito","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16942","reference":[{"issue":"1","key":"key20260914141126_B1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.pcl.2018.09.004","article-title":"Hypophosphatemic rickets","volume":"66","author":"Bitzan","year":"2019","unstructured":"1 Bitzan M, Goodyer PR. Hypophosphatemic rickets. Pediatr Clin North Am. 2019;66(1):179-207.","journal-title":"Pediatr Clin North Am"},{"issue":"7","key":"key20260914141126_B2","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jbmr.340","article-title":"A clinician's guide to X-linked hypophosphatemia","volume":"26","author":"Carpenter","year":"2011","unstructured":"2 Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KL. A clinician's guide to X-linked hypophosphatemia. J Bone Miner Res. 2011;26(7):1381-8.","journal-title":"J Bone Miner Res"},{"key":"key20260914141126_B3","doi-asserted-by":"crossref","first-page":"699767","DOI":"10.3389\/fped.2021.699767","article-title":"Genotype and Phenotype Analysis in X-Linked Hypophosphatemia","volume":"9","author":"Park","year":"2021","unstructured":"3 Park PG, Lim SH, Lee H, Ahn YH, Cheong HI, Kang HG. Genotype and Phenotype Analysis in X-Linked Hypophosphatemia. Front Pediatr. 2021;9:699767.","journal-title":"Front Pediatr"},{"issue":"4","key":"key20260914141126_B4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00439-009-0631-z","article-title":"PHEX analysis in 118 pedigrees reveals new genetic clues in hypophosphatemic rickets","volume":"125","author":"Gaucher","year":"2009","unstructured":"4 Gaucher C, Walrant-Debray O, Nguyen TM, Esterle L, Garab\u00e9dian M, Jehan F. PHEX analysis in 118 pedigrees reveals new genetic clues in hypophosphatemic rickets. Hum Genet. 2009;125(4):401-11.","journal-title":"Hum Genet"},{"issue":"7","key":"key20260914141126_B5","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1210\/js.2018-00365","article-title":"The Lifelong Impact of X-Linked Hypophosphatemia: Results From a Burden of Disease Survey","volume":"3","author":"Skrinar","year":"2019","unstructured":"5 Skrinar A, Dvorak-Ewell M, Evins A, Macica C, Linglart A, Imel EA, et al. The Lifelong Impact of X-Linked Hypophosphatemia: Results From a Burden of Disease Survey. J Endocr Soc. 2019;3(7):1321-34.","journal-title":"J Endocr Soc"},{"issue":"2","key":"key20260914141126_B6","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/0022034517728497","article-title":"Defective Mineralization in X-Linked Hypophosphatemia Dental Pulp Cell Cultures","volume":"97","author":"Coyac","year":"2018","unstructured":"6 Coyac BR, Hoac B, Chafey P, Falgayrac G, Slimani L, Rowe PS, et al. Defective Mineralization in X-Linked Hypophosphatemia Dental Pulp Cell Cultures. J Dent Res. 2018;97(2):184-91.","journal-title":"J Dent Res"},{"issue":"2","key":"key20260914141126_B7","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00223-010-9373-0","article-title":"Phenotype presentation of hypophosphatemic rickets in adults","volume":"87","author":"Beck-Nielsen","year":"2010","unstructured":"7 Beck-Nielsen SS, Brusgaard K, Rasmussen LM, Brixen K, Brock-Jacobsen B, Poulsen MR, et al. Phenotype presentation of hypophosphatemic rickets in adults. Calcif Tissue Int. 2010;87(2):108-19.","journal-title":"Calcif Tissue Int"},{"issue":"5-6","key":"key20260914141126_B8","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s10354-019-00732-2","article-title":"Multidisciplinary patient care in X-linked hypophosphatemic rickets: one challenge, many perspectives","volume":"170","author":"Raimann","year":"2020","unstructured":"8 Raimann A, Mindler GT, Kocijan R, Bekes K, Zwerina J, Haeusler G, Ganger R. Multidisciplinary patient care in X-linked hypophosphatemic rickets: one challenge, many perspectives. Wien Med Wochenschr. 2020;170(5-6):116-23. Review.","journal-title":"Wien Med Wochenschr"},{"issue":"1","key":"key20260914141126_B9","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/EC-13-0103","article-title":"Therapeutic management of hypophosphatemic rickets from infancy to adulthood","volume":"3","author":"Linglart","year":"2014","unstructured":"9 Linglart A, Biosse-Duplan M, Briot K, Chaussain C, Esterle L, Guillaume-Czitrom S, et al. Therapeutic management of hypophosphatemic rickets from infancy to adulthood. Endocr Connect. 2014;3(1):R13-30.","journal-title":"Endocr Connect"},{"issue":"10189","key":"key20260914141126_B10","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/S0140-6736(19)30654-3","article-title":"Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial","volume":"393","author":"Imel","year":"2019","unstructured":"10 Imel EA, Glorieux FH, Whyte MP, Munns CF, Ward LM, Nilsson O, et al. Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial. Lancet. 2019;393(10189):2416-27.","journal-title":"Lancet"},{"issue":"2","key":"key20260914141126_B11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/humu.24296","article-title":"Novel PHEX gene locus-specific database: comprehensive characterization of vast number of variants associated with X-linked hypophosphatemia (XLH)","volume":"43","author":"Sarafrazi","year":"2022","unstructured":"11 Sarafrazi S, Daugherty SC, Miller N, Boada P, Carpenter TO, Chunn L, et al. Novel PHEX gene locus-specific database: comprehensive characterization of vast number of variants associated with X-linked hypophosphatemia (XLH). Hum Mutat. 2022;43(2):143-57.","journal-title":"Hum Mutat"},{"issue":"12","key":"key20260914141126_B12","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaa151","article-title":"X-Linked Hypophosphatemia: A New Era in Management","volume":"4","author":"Dahir","year":"2020","unstructured":"12 Dahir K, Roberts MS, Krolczyk S, Simmons JH. X-Linked Hypophosphatemia: A New Era in Management. J Endocr Soc. 2020;4(12):bvaa151.","journal-title":"J Endocr Soc"},{"issue":"11","key":"key20260914141126_B13","first-page":"4075","article-title":"X-linked hypophosphatemia: a search for gender, race, anticipation, or parent of origin effects on disease expression in children","volume":"81","author":"Whyte","year":"1996","unstructured":"13 Whyte MP, Schranck FW, Armamento-Villareal R. X-linked hypophosphatemia: a search for gender, race, anticipation, or parent of origin effects on disease expression in children. J Clin Endocrinol Metab. 1996;81(11):4075-80.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"key20260914141126_B14","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s10545-018-0147-6","article-title":"Outcome of adult patients with X-linked hypophosphatemia caused by PHEX gene mutations","volume":"41","author":"Chesher","year":"2018","unstructured":"14 Chesher D, Oddy M, Darbar U, Sayal P, Casey A, Ryan A, et al. Outcome of adult patients with X-linked hypophosphatemia caused by PHEX gene mutations. J Inherit Metab Dis. 2018;41(5):865-76.","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"key20260914141126_B15","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/hmg\/6.4.539","article-title":"Distribution of mutations in the PEX gene in families with X-linked hypophosphataemic rickets (HYP)","volume":"6","author":"Rowe","year":"1997","unstructured":"15 Rowe PS, Oudet CL, Francis F, Sinding C, Pannetier S, Econs MJ, et al. Distribution of mutations in the PEX gene in families with X-linked hypophosphataemic rickets (HYP). Hum Mol Genet. 1997;6(4):539-49.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"key20260914141126_B16","first-page":"790","article-title":"Mutational analysis of the PEX gene in patients with X-linked hypophosphatemic rickets","volume":"60","author":"Holm","year":"1997","unstructured":"16 Holm IA, Huang X, Kunkel LM. Mutational analysis of the PEX gene in patients with X-linked hypophosphatemic rickets. Am J Hum Genet. 1997;60(4):790-7.","journal-title":"Am J Hum Genet"},{"key":"key20260914141126_B17","doi-asserted-by":"crossref","first-page":"154049","DOI":"10.1016\/j.metabol.2019.154049","article-title":"Management of X-linked hypophosphatemia in adults","volume":"103S","author":"Lecoq","year":"2020","unstructured":"17 Lecoq AL, Brandi ML, Linglart A, Kamenick\u00fd P. Management of X-linked hypophosphatemia in adults. Metabolism. 2020;103S:154049.","journal-title":"Metabolism"},{"issue":"3","key":"key20260914141126_B18","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1210\/clinem\/dgab729","article-title":"Sustained Efficacy and Safety of Burosumab, a Monoclonal Antibody to FGF23, in Children With X-Linked Hypophosphatemia","volume":"107","author":"Linglart","year":"2022","unstructured":"18 Linglart A, Imel EA, Whyte MP, Portale AA, H\u00f6gler W, Boot AM, et al. Sustained Efficacy and Safety of Burosumab, a Monoclonal Antibody to FGF23, in Children With X-Linked Hypophosphatemia. J Clin Endocrinol Metab. 2022;107(3):813-24.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"key20260914141126_B19","doi-asserted-by":"crossref","first-page":"e3241","DOI":"10.1210\/clinem\/dgac296","article-title":"Effect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked Hypophosphatemia","volume":"107","author":"Ward","year":"2022","unstructured":"19 Ward LM, Glorieux FH, Whyte MP, Munns CF, Portale AA, H\u00f6gler W, et al. Effect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked Hypophosphatemia. J Clin Endocrinol Metab. 2022;107(8):e3241-53.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"key20260914141126_B20","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1530\/EC-20-0291","article-title":"Clinical guidelines for burosumab in the treatment of XLH in children and adolescents: british paediatric and adolescent bone group recommendations","volume":"9","author":"Padidela","year":"2020","unstructured":"20 Padidela R, Cheung MS, Saraff V, Dharmaraj P. Clinical guidelines for burosumab in the treatment of XLH in children and adolescents: british paediatric and adolescent bone group recommendations. Endocr Connect. 2020;9(10):1051-6.","journal-title":"Endocr Connect"},{"issue":"5","key":"key20260914141126_B21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/archdischild-2022-324962","article-title":"Burosumab in management of X-linked hypophosphataemia: a retrospective cohort study of growth and serum phosphate levels","volume":"108","author":"Walker","year":"2023","unstructured":"21 Walker EY, Lindsay TA, Allgrove J, Marlais M, Bockenhauer D, Hayes W. Burosumab in management of X-linked hypophosphataemia: a retrospective cohort study of growth and serum phosphate levels. Arch Dis Child. 2023; 108(5):379-84.","journal-title":"Arch Dis Child"}],"container-title":["einstein (S\u00e3o Paulo)"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:11:34Z","timestamp":1789395094000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.einstein.br\/article\/x-linked-hypophosphatemic-rickets-case-report-with-perspectives-and-challenges\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":21,"alternative-id":["10.31744\/einstein_journal\/2026RC1788"],"URL":"https:\/\/doi.org\/10.31744\/einstein_journal\/2026rc1788","relation":{},"ISSN":["1679-4508","2317-6385"],"issn-type":[{"value":"1679-4508","type":"print"},{"value":"2317-6385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"eRC1788"}}